Mirum Pharmaceuticals Stock Price

-1.71 (-7.97%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Mirum Pharmaceuticals Inc MIRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.71 -7.97% 19.74 17:37:40
Close Price Low Price High Price Open Price Previous Close
19.74 19.67 21.965 21.56 21.45
Bid Price Ask Price Spread News
19.74 25.35 5.61 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,295 208,513 $ 20.69 $ 4,314,460 82,191 6.5126 - 28.31
Last Trade Time Type Quantity Stock Price Currency
16:29:08 44 $ 19.7417 USD

Mirum Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 501.38M 25.40M 11.86M $ - $ - -2.13 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.10%

more financials information »

Mirum Pharmaceuticals News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MIRM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.7022.34518.1420.8352,5560.040.2%
1 Month24.1826.9918.1421.6481,395-4.44-18.36%
3 Months20.5727.4317.83421.8971,481-0.83-4.04%
6 Months10.3227.439.1418.6476,6549.4291.28%
1 Year9.4328.316.512618.48139,69810.31109.33%
3 Years13.0028.316.512618.03130,7786.7451.85%
5 Years13.0028.316.512618.03130,7786.7451.85%

Mirum Pharmaceuticals Description

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Your Recent History
Mirum Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200920 18:24:13